A novel missense mutation of folypolyglutamate synthetase gene

HU Chun-Yan, YUE Li-Jie, YU Jie, ZHANG Hong-Hong, YANG Chun-Lan

Chinese Journal of Contemporary Pediatrics ›› 2012, Vol. 14 ›› Issue (07) : 529-532.

PDF(1103 KB)
PDF(1103 KB)
Chinese Journal of Contemporary Pediatrics ›› 2012, Vol. 14 ›› Issue (07) : 529-532.
CLINICAL RESEARCH

A novel missense mutation of folypolyglutamate synthetase gene

  • HU Chun-Yan, YUE Li-Jie, YU Jie, ZHANG Hong-Hong, YANG Chun-Lan
Author information +
History +

Abstract

OBJECTIVE: To examine allelic frequencies of coding single nucleotide polymorphisms (cSNPs) of folypolyglutamate synthetase (FPGS) gene in Chinese Han children with acute leukemia (AL), in order to provide a basis for detecting the relationship between FPGS genetic polymorphisms and tumor individualized chemotherapy. METHODS: cSNPs of exon 5 were detected with polymerase chain reaction (PCR) - denaturing gradient gel electrophoresis (DGGE) in 91 children with AL and 124 children with upper respiratory infection as controls. Genotypes and allelic frequencies were examined. RESULTS: A novel missense mutation, 502/490 T>C (L151/101P), was found in exon 5 of FPGS from control children. The novel mutation was found in mitochondrial variants in two cases and cytosolic variants in three cases. The cytosolic and mitochondrial variants displayed allelic frequencies of 0.70 % and 0.47 % respectively. The novel mutation was not associated with susceptibility to AL. CONCLUSIONS: A novel missense mutation 502/490 T>C (L151/101P) in exon 5 of FPGS gene is firstly found in Chinese Han children, and the cytosolic and mitochondrial variants display allelic frequencies of 0.70 % and 0.47 % respectively.

Key words

Folypolyglutamate synthetase gene / Single nucleotide polymorphism / Acute leukemia / Child

Cite this article

Download Citations
HU Chun-Yan, YUE Li-Jie, YU Jie, ZHANG Hong-Hong, YANG Chun-Lan. A novel missense mutation of folypolyglutamate synthetase gene[J]. Chinese Journal of Contemporary Pediatrics. 2012, 14(07): 529-532

References

[1]Gorlick R, Groken E, Trippett T, Waltham M, Banerjee D, Bertino JR. Intrinsic and acquired resistance to methotrexate an acute leukamia[J]. N Engl J Med,1996, 335(14): 1041-1048.

[2]Wang Y, Zhao R, Goldman I. Decreased expression of  the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate  (LY231514)  in an L1210 murine leukemia  cell line[J]. Biochem Pharmacol, 2003, 65(7): 1163-1170.

[3]Liani E, Rothem L, Bunni M, Smith C, Jansen G, Assaraf YG. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines[J]. Int J  Cancer, 2003, 103(5): 587-599.

[4]Stark M, Wichman C, Avivi I, Assaraf YG. Aberrant  splicing  of  folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia[J]. Blood, 2009, 113(18): 4363-4369.

[5]孙利,沈佐君,何晓东. 氨甲蝶呤对映体耐药A549细胞株中叶酰聚谷氨酸合成酶mRNA和蛋白表达[J]. 安徽医科大学学报,2011,46(6):549-522.

[6]Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, Miyamae T, et al. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis[J]. Br J Clin Pharmacol, 2011, 71(2): 237-243.

[7]Adjei AA, Mandrekar SJ, Dy GK, Molina JR, Adjei AA, Gandara DR, et al. Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced nonsmallcell lung cancer: NCCTG and SWOG study N0426[J]. J Clin Oncol, 2010, 28(4): 614-619.

[8]杨天楹.急性白血病[M]//张之南. 血液病诊断及疗效标准.第2版.北京: 科学出版社,1998:168-214.

[9]McGuire JJ, Russell CA, Balinska M. Human cytosolic and mitochondrial folylpolyglutamate synthetase are electrophoretically distinct. Expression in antifolate-sensitive andresistant human cell lines[J]. J Bio Chem, 2000, 275(17):13012-13016.

[10]Leclerc GJ, York TA, HsiehKinser T, Barredo JC. Molecular basis for decreased folypoly-gamma-glutamate synthetase expression in a methotrexate resistant CCRF-CEM mutatant cell line[J]. Leu Res, 2007, 31(3): 293-299.

[11]Figueiredo JC, Levine AJ, Lee WH, Lonti DV, Poynter JN, Campbell PT, et al. Genes involved with folate uptake and distribution and their association with colorectal cancer risk[J]. Cancer Causes Control, 2010, 21(4): 597-608.

[12]Warren RB, Smith RL, Campalani E, Eyre S, Smith CH, Barker JN, et al. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms[J]. Br J Dermatol, 2009, 160(2): 438-441.
PDF(1103 KB)

Accesses

Citation

Detail

Sections
Recommended

/